Causes of Euthyroid Multinodular Goiter

1. Iodine Deficiency (Most Common Worldwide)

• In iodine-deficient populations (Central Asia, South America, Indonesia), up to 90% of the population may be affected.
• In iodine-replete regions (US, Western Europe), sporadic MNG is the most common nontoxic goiter form (~5% incidence).
• TSH levels are often only slightly elevated or even normal, suggesting increased TSH sensitivity or activation of parallel growth pathways.

Iodide also has direct effects on thyroid vasculature and may indirectly modulate growth through vasoactive mediators like endothelins and nitric oxide. - Harrison's Principles of Internal Medicine 22e, p. 3084

2. Dietary Goitrogens

3. TSH Stimulation and Paracrine Growth Factors

• Elevated TSH drives diffuse thyroid hyperplasia → focal hyperplasia → nodule formation
• Nodules may concentrate iodine (hot), fail to do so (cold), or become colloid nodules
• Over time, TSH-dependent nodules may develop autonomy (hence future risk of Plummer disease/toxic MNG)
• Local paracrine growth factors and cytokines (IGF-1, EGF, FGF) amplify this process independent of TSH

"Most nodules within an MNG are polyclonal in origin, suggesting a hyperplastic response to locally produced growth factors and cytokines." - Harrison's 22e

4. Genetic and Hereditary Factors

5. Goitrogenic Drugs and Medications

6. Autoimmune Mechanisms

7. Age and Sex

• MNG prevalence increases with age (paralleling age-related thyroid nodule incidence generally)
• Women are significantly more affected than men (likely hormonal influence)
• These are modifiers rather than independent causes

Summary: Classification of Causes

Pathogenetic Summary

1. Follicular heterogeneity (some cells more responsive than others)
2. Focal proliferation of cells with acquired growth advantages
3. Areas of fibrosis, hemorrhage, cystic degeneration, and calcification
4. Coexistence of polyclonal hyperplastic nodules and monoclonal neoplastic-like nodules

"Recurrent episodes of hyperplasia and involution combine to produce a more irregular enlargement of the thyroid, termed multinodular goiter." - Robbins & Cotran Pathologic Basis of Disease

Differential Diagnosis: Euthyroid vs. Toxic Multinodular Goiter

Pathophysiologic Basis of the Distinction

• In euthyroid MNG, nodules are present but TSH-dependent thyroid tissue still dominates - normal hormone levels are maintained.
• In toxic MNG, one or more nodules develop TSH-independent (autonomous) secretion, suppressing TSH and eventually raising T3 and/or T4 above normal.
• The transition is gradual and often passes through a subclinical hyperthyroid phase (suppressed TSH, normal free T3/T4) before progressing to overt thyrotoxicosis.

"The pathogenesis of toxic MNG appears to be similar to that of nontoxic MNG; the major difference is the presence of functional autonomy in toxic MNG." - Harrison's Principles of Internal Medicine 22e

Comparative Table: Euthyroid vs. Toxic MNG

Clinical Features in Detail

Euthyroid MNG

• Most patients are asymptomatic and discovered incidentally on imaging or exam
• Symptoms, if present, are purely mechanical: dysphagia, inspiratory stridor, neck fullness, Pemberton's sign (facial suffusion on arm elevation - thoracic inlet obstruction), sudden pain from hemorrhage into a nodule
• No symptoms of thyroid hormone excess
• Hoarseness raises suspicion for malignancy

Toxic MNG

• Typically in an older woman (>50) with a known long-standing goiter
• Insidious onset of thyrotoxicosis - often subclinical first
• Common presentations include atrial fibrillation or other cardiac arrhythmias (often the presenting feature in the elderly, rather than classic adrenergic symptoms)
• Weight loss, heat intolerance, tremor, anxiety, fatigue
• No exophthalmos or pretibial myxedema - this is key to distinguishing it from Graves disease

"The characteristic patient has a long history of thyroid enlargement with insidious development of subclinical and then subsequently overt thyrotoxicosis. These patients generally do not have ophthalmopathy or localized myxedema." - Cummings Otolaryngology

Laboratory Differentiation

Scintigraphic (Nuclear Scan) Differentiation

Distinguishing Toxic MNG from Graves Disease (Key Differential)

"Laboratory testing demonstrates the absence of TSI and/or TrAb [in toxic MNG]." - Mulholland & Greenfield's Surgery 7e

Progression: Euthyroid → Subclinical → Overt Toxic MNG

Euthyroid MNG
    ↓ (years to decades - accumulation of autonomous tissue)
Subclinical Hyperthyroidism (suppressed TSH, normal T3/T4)
    ↓ (especially after iodine load - Jod-Basedow)
Overt Toxic MNG (suppressed TSH + elevated T3 and/or T4)

• Subclinical hyperthyroidism from TMNG is more likely to persist or progress (vs. Graves, which may remit)
• Iodine exposure (contrast agents, amiodarone) can precipitate this transition in patients with pre-existing autonomous nodules

Summary: The Key Differentiating Points

1. TSH - the single most important test: normal in euthyroid MNG, suppressed in toxic MNG
2. Free T3/T4 - normal in euthyroid, elevated in overt toxic MNG (T3 often rises first)
3. Symptoms of thyrotoxicosis - present only in toxic MNG; compressive symptoms are shared
4. Scintigraphy - hot autonomous nodules visible in toxic MNG, absent in euthyroid MNG
5. TRAb/TSI - absent in both (distinguishes both from Graves disease)
6. No spontaneous remission - toxic MNG does not remit; euthyroid MNG may stabilize

Total Knee Replacement (TKA) - Step by Step

Phase 1: Preoperative Planning

• Long-standing weight-bearing radiographs (full-limb AP) to measure the hip-knee-ankle (mechanical) axis, the femoral anatomic-to-mechanical axis angle (typically 5-7 degrees valgus), and the degree of deformity (varus/valgus).
• Lateral and skyline patellar views to assess patellofemoral tracking and patellar height.
• Component templating - sizing femoral and tibial components to match the patient's bone dimensions.
• The angle between the anatomic and mechanical femoral axes determines the valgus cut angle for the distal femoral resection.

Phase 2: Anesthesia and Positioning

• General, spinal, or regional (femoral nerve block + spinal) anesthesia.
• Patient supine on the operating table.
• A tourniquet is applied to the upper thigh (inflated to ~100 mmHg above systolic pressure). Tourniquet use is increasingly selective - some surgeons operate without it to reduce postoperative pain and muscle damage.
• The operative limb is prepped and draped free.
• The leg is positioned in a leg holder or foot rest that maintains the knee at ~90 degrees of flexion for most of the bony work.

Phase 3: Surgical Approach and Exposure

Skin Incision (Technique 8.1, Campbell's)

1. The knee is flexed before incision - this allows the subcutaneous tissue to fall medially and laterally, improving exposure and reducing tension.
2. A straight anterior midline skin incision is made, extending from ~5 cm above the patella to the tibial tubercle. This is the most common approach.
3. If a prior scar exists, it is incorporated. When multiple scars are present, the most lateral is preferred (blood supply to anterior knee skin comes predominantly from the medial side).
4. The incision must be long enough to avoid excessive retraction tension, which can cause skin necrosis.

Deep Approach: Medial Parapatellar Arthrotomy

1. The retinacular incision follows the medial parapatellar approach - the most standard deep approach. The incision runs along the quadriceps tendon (leaving a 3-4 mm cuff on the vastus medialis for later closure), around the medial border of the patella, and down 3-4 cm along the anteromedial tibia beside the patellar tendon.
2. The medial skin flap is kept as thick as possible, staying just superficial to the extensor mechanism.
3. The anteromedial capsule and deep medial collateral ligament (MCL) are subperiosteally elevated off the proximal tibia to the posteromedial corner.
4. The knee is extended and the patella is everted (or subluxated laterally in obese patients) to expose the entire joint. Lateral patellofemoral plicae are released.

Alternative approaches include the subvastus (muscle-splitting) approach and midvastus approach, which preserve the vastus medialis insertion and may allow faster rehabilitation - but expose differently and are harder in stiff or obese knees.

Initial Joint Preparation

1. The knee is flexed after exposure.
2. The ACL is excised (TKA sacrifices the ACL in all designs; the PCL is either retained or sacrificed depending on implant type).
3. The anterior horns of both menisci are removed.
4. All osteophytes - especially medial, peripheral, and posterior - are removed with a rongeur or osteotome. Peripheral osteophytes tether the capsule and cause false ligament tightness; their removal is essential for accurate soft-tissue balancing.

Phase 4: Bone Resection - The Five Cuts

Cut 1: Distal Femoral Resection

• An intramedullary (IM) rod is introduced through a drill hole in the distal femur (about 1 cm anterior to the PCL femoral attachment) to set the valgus angle.
• The distal femoral cutting guide is set at 5-7 degrees of valgus relative to the femoral shaft axis (this corrects for the angle between the anatomic and mechanical femoral axes and restores the mechanical axis to neutral).
• Bone removed equals the thickness of the distal femoral component (typically 9-10 mm).
• If a significant flexion contracture is present, 1-2 mm of additional distal femoral bone can be removed (but elevation of joint line >4 mm is avoided).
• If a PCL-substituting (posterior-stabilized) design is used, an extra 2 mm can be taken to compensate for the larger flexion gap created by PCL sacrifice.

Cut 2: Proximal Tibial Resection

• An extramedullary tibial alignment guide is applied. The rod is aimed from the center of the proximal tibia to slightly medial to the center of the ankle (between the malleoli).
• The tibial cut is made perpendicular to the mechanical tibial axis in the coronal plane and with 0-7 degrees of posterior slope in the sagittal plane (slope varies by implant design and surgeon preference; PCL-retaining designs often use more slope).
• The amount of bone resected from the less-worn side (usually lateral tibia in varus knee) is typically 8-10 mm (the minimum amount to seat the tibial component and allow adequate polyethylene insert thickness).
• The tibial cut is the most important for restoring limb alignment.

Cut 3-5: Anterior, Posterior, and Chamfer Femoral Cuts

• A sizing guide is applied to the resected distal femur to determine femoral component size.
• Femoral component rotation is set - this is critical for patellar tracking and flexion gap symmetry:
  • Referenced to the transepicondylar axis (most reliable - posterior cut parallel to a line between medial and lateral epicondyles)
  • Or to the AP (Whiteside) axis (perpendicular to a line from the trochlear groove to the intercondylar notch)
  • Or 3 degrees of external rotation from the posterior condylar axis
• The anterior femoral cut removes bone to create the trochlear groove for the femoral component.
• The posterior femoral cuts (medial and lateral) shape the flexion gap.
• Chamfer cuts (anterior and posterior bevel cuts, typically 4 in number) connect the flat distal, anterior, and posterior cuts, producing the curved distal profile of the femoral component.

Key principle: Excessive external rotation widens the medial flexion gap causing flexion instability. Internal rotation causes lateral patellar tilt and patellofemoral problems.

Phase 5: Soft-Tissue Balancing

• Tensor/spacer blocks or trial components are inserted to measure gap size and symmetry.
• If gaps are unequal or imbalanced, soft-tissue releases are performed:
  • Varus deformity → release posteromedial capsule, superficial MCL, semimembranosus (pie-crusting or sequential release)
  • Valgus deformity → release iliotibial band (ITB), posterolateral capsule, popliteus tendon
  • Flexion contracture → posterior capsule release, additional distal femoral resection

Phase 6: Patellar Resurfacing

• The patellar articular surface is resected with a patellar cutting guide to a measured depth (typically leaving 12-15 mm of bone thickness - the "rule of residual patella").
• A patellar component (dome-shaped polyethylene button) is cemented onto the resected surface.
• The patellar tracking ("no-thumb test") is assessed with trial components - the patella should track centrally in the trochlear groove without lateral tilt or subluxation throughout the range of motion.
• If tracking is poor, a lateral retinacular release is performed.
• Patellar resurfacing remains controversial in non-rheumatoid cases, but is standard practice in most centers and endorsed by the ATA guidelines.

Phase 7: Trial Reduction and Assessment

• Trial femoral, tibial, and patellar components are inserted.
• The knee is taken through a full range of motion (0-130 degrees).
• The surgeon checks:
  • Stability in extension, mid-flexion, and 90 degrees
  • Patellar tracking (no lateral tilt or subluxation)
  • Ligament balance (medial/lateral tension symmetry)
  • Flexion-extension gap equality
  • Tibial rotation (the tibial component should follow the tibia naturally through the arc of motion)
• If unsatisfactory, additional releases or bone adjustments are made before cementing.

Phase 8: Cementation and Final Implant Insertion

1. Pulse lavage the cut bone surfaces to remove fat, blood, and marrow elements - this dramatically improves cement interdigitation and implant fixation.
2. Tibial component first - cement is applied to the tibial tray and/or bone surface; the tibial component is impacted and held under pressure. Excess cement is removed from around the margins before it sets.
3. Femoral component - cement applied and the femoral component impacted; posterior cement removal is critical (retained posterior cement causes restricted flexion and pain).
4. Patellar component - cemented separately with the knee in flexion for access.
5. Polyethylene tibial insert is then locked or snap-fit into the tibial tray (not cemented).
6. The tourniquet is deflated (if used), and hemostasis is obtained. Electrocautery is used carefully.

Cementless (press-fit) fixation is an alternative - porous metal surfaces encourage bone ingrowth. Increasingly used in younger, active patients. Requires accurate fit and initial stability.

Phase 9: Final Assessment

• The knee is reduced with all final components in place.
• Full range of motion is checked again.
• Patellar tracking re-assessed.
• Stability confirmed in extension and flexion.
• Hemostasis secured throughout the joint.

Phase 10: Wound Closure

1. Joint capsule and retinaculum are closed with heavy interrupted or running absorbable sutures (e.g., No. 1 Vicryl). The medial parapatellar arthrotomy is closed in layers - quadriceps tendon cuff, peripatellar retinaculum, and anteromedial capsule.
2. Subcutaneous layer - closed with absorbable sutures.
3. Skin - closed with staples, interrupted nylon, or subcuticular suture depending on surgeon preference.
4. A surgical drain may or may not be placed (trend is away from routine drainage).
5. Sterile dressing is applied. A compression bandage or cold therapy device may be applied.

Phase 11: Immediate Postoperative Care

• VTE prophylaxis begins (aspirin, LMWH, or direct oral anticoagulants).
• Multimodal analgesia: regional nerve blocks (femoral, adductor canal), spinal adjuvants, NSAIDs, acetaminophen, periarticular local anesthetic injections.
• Physiotherapy begins Day 0 or Day 1: weight bearing as tolerated (WBAT) with a walking frame.
• Knee flexion exercises to prevent stiffness; goal of 90 degrees by discharge.
• Continuous passive motion (CPM) is now largely abandoned in favor of active mobilization.

Summary Diagram: The Five Bone Cuts

FEMUR
  ┌─────────────────────────────────────┐
  │  1. DISTAL FEMORAL CUT              │  ← 5-7° valgus to mechanical axis
  │  2. ANTERIOR FEMORAL CUT            │  ← Sets anterior trochlear housing
  │  3. POSTERIOR FEMORAL CUT           │  ← External rotation reference
  │  4. ANTERIOR CHAMFER CUT            │  ↘
  │  5. POSTERIOR CHAMFER CUT           │  ↗  Bevel transitions
  └─────────────────────────────────────┘

TIBIA
  ┌─────────────────────────────────────┐
  │  PROXIMAL TIBIAL CUT                │  ← Perpendicular to mechanical axis
  │                                     │    + 0-7° posterior slope
  └─────────────────────────────────────┘

PATELLA
  ┌─────────────────────────────────────┐
  │  PATELLAR RESECTION                 │  ← Leave ≥12-15 mm bone
  └─────────────────────────────────────┘

Modern Adjuncts